title: Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection.
authors: Infectious Diseases Department, San Raffaele Scientific Institute, Milan, Italy nozza.silvia@hsr.it.
authors: Silvia
authors: S
authors: Nozza
authors: Infectious Diseases Department, San Raffaele Scientific Institute, Milan, Italy.
authors: Andrea
authors: A
authors: Poli
authors: Infectious Diseases Department, San Raffaele Scientific Institute, Milan, Italy.|Università Vita-Salute San Raffaele, Milan, Italy.
authors: Marco
authors: M
authors: Ripa
authors: Infectious Diseases Department, San Raffaele Scientific Institute, Milan, Italy.|Università Vita-Salute San Raffaele, Milan, Italy.
authors: Laura
authors: L
authors: Galli
authors: Infectious Diseases Department, San Raffaele Scientific Institute, Milan, Italy.|Università Vita-Salute San Raffaele, Milan, Italy.
authors: Stefania
authors: S
authors: Chiappetta
authors: Infectious Diseases Department, San Raffaele Scientific Institute, Milan, Italy.
authors: Vincenzo
authors: V
authors: Spagnuolo
authors: Università Vita-Salute San Raffaele, Milan, Italy.
authors: Cristina
authors: C
authors: Rovelli
authors: Infectious Diseases Department, San Raffaele Scientific Institute, Milan, Italy.|Università Vita-Salute San Raffaele, Milan, Italy.
authors: Adriano
authors: A
authors: Lazzarin
authors: Infectious Diseases Department, San Raffaele Scientific Institute, Milan, Italy.|Università Vita-Salute San Raffaele, Milan, Italy.
authors: Antonella
authors: A
authors: Castagna
authors: Infectious Diseases Department, San Raffaele Scientific Institute, Milan, Italy.
authors: Giuseppe
authors: G
authors: Tambussi
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D000069547:Cobicistat / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000068679:Emtricitabine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006678:HIV / Q000187:drug effects* / Q000235:genetics; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D008297:Male; D008875:Middle Aged; D015363:Quinolones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D012189:Retrospective Studies; D000068698:Tenofovir / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D016896:Treatment Outcome; D019562:Viral Load / Q000187:drug effects
chemical_list: D019380:Anti-HIV Agents; D015363:Quinolones; C509700:elvitegravir; D000068698:Tenofovir; D000068679:Emtricitabine; D000069547:Cobicistat